Article info
PDFEditorial
NICE discrimination
- Correspondence to: Professor SirMichael Rawlins National Institute for Health and Clinical Excellence, MidCity Place, 71 High Holborn, London WC1V 6NA, UK; michael.rawlins{at}nice.org.uk
Citation
NICE discrimination
Publication history
- Received July 29, 2005
- Accepted August 21, 2005
- First published November 30, 2005.
Online issue publication
November 30, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Nice and not so nice
- National Institute for Clinical Excellence and its value judgments
- A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
- Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy
- Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
- Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
- NICE and neurology
- Wickedness or folly? The ethics of NICE’s decisions
- Screening for postnatal depression in primary care: cost effectiveness analysis
- The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk